Company: BIAF
Filing Date: 2025-05-07
Form Type: 424B4
Source: 0001641172-25-008977
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-07
Form: 424B4
Chunk 0
---
| PROSPECTUS |     | Filed                      
 Pursuant to Rule 424(b)(4) |
|            |     | Registration               
 No. 333-286921             |

<div align='center'>Up to 7,784,904 Shares of Common Stock

Pre-Funded Warrants to Purchase up to 2,371,346 Shares of Common Stock

Warrants to Purchase up to 19,804,687 Shares of Common Stock

Placement Agent Warrants to Purchase up to 304,687 Shares of Common Stock

Up to 22,480,720 Shares of Common Stock Issuable Upon Exercise of

Pre-Funded Warrants, Warrants and Placement Agent Warrants</div>

We are offering up to 7,784,904 shares (the “Shares”) of our common stock, par value $0.007 per share (the “Common Stock”), pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 2,371,346 shares of Common Stock in lieu of Shares, together with warrants (the “May 2025 Warrants”) to purchase up to 19,804,687 shares of Common Stock. The number of shares of Common Stock issuable upon exercise of the May 2025 Warrants and offered hereby is equal to 150% of the number of Shares and Pre-Funded Warrants, plus an additional 30% increase in the number of shares of Common Stock that would be issuable upon exercise of the May 2025 Warrants if a reverse stock split is effected prior to the expiration of the May 2025 Warrants(the “Reverse Stock Split Adjustment”). This registration statement does not register the issuance of up to an additional 49,907,811 shares of Common Stock which are issuable upon exercise of the May 2025 Warrants pursuant to pursuant to the Anti-Dilution Adjustment (as defined below) contained therein. The combined public offering price for each share of Common Stock and accompanying May 2025 Warrant to purchase one and one-half share of Common Stock is $0.32. Each share of our Common Stock is being sold together with one May 2025 Warrant to initially purchase one and one-half share of Common Stock.

The May 2025 Warrants will have an initial exercise price of $0.352 per share (110% of the combined public offering price per share of Common Stock and accompanying May 2025 Warrant) and will be immediately exercisable, except that the issuance of shares of Common